In order to investigate the potential clinical implications of MEOX1 in breast cancer patients, we performed immunohistological staining of MEOX1 in a breast cancer tissue microarray (TMA) containing tumor samples and associated survival data (N=150). The gene discussed is MEOX1; the disease is breast carcinoma.